Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

81.98 -2.23 (-2.65%)
Streaming Delayed Price Updated: 10:09 AM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
What 15 Analyst Ratings Have To Say About Illumina
Via Benzinga
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal
Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025. 
Via Benzinga
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%
Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings. 
Via Benzinga
3 Volatile Stocks with Mounting Challenges
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
Earnings Scheduled For May 8, 2025
Via Benzinga
Illumina Analysts Lower Their Forecasts After Q1 Results
Via Benzinga
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Illumina’s (NASDAQ:ILMN) Q1 Sales Top Estimates
Genomics company Illumina (NASDAQ:ILMN) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 1.4% year on year to $1.04 billion. Its non-GAAP profit of $0.97 per share... 
Via StockStory
Earnings To Watch: Illumina (ILMN) Reports Q1 Results Tomorrow
Genomics company Illumina (NASDAQ:ILMN) will be announcing earnings results this Thursday afternoon. Here’s what to expect. 
Via StockStory
Assessing Illumina: Insights From 16 Financial Analysts
Via Benzinga
Rep. Thomas Kean Has Bought Up to $45K Worth Of Illumina Stock: Here's What You Should Know
Via Benzinga
Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Illumina (NASDAQ:ILMN) and the... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:ILMN),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:MDAI) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Healthcare Stock for Long-Term Investors and 2 to Keep Off Your Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
From FN Media Group LLC
Via GlobeNewswire
Got $3,000? 2 Artificial Intelligence (AI) Stocks to Buy and Hold for the Long Term
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Deep Dive Into Illumina Stock: Analyst Perspectives (14 Ratings)
Via Benzinga
Apple To $250? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
How Do Investors Really Feel About Illumina?
Via Benzinga
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
Via Benzinga
3 Mid-Cap Stocks Walking a Fine Line
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
The Future of Healthcare: 10 Predictions For The Next Decade
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we... 
Via MarketMinute
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
The Future of the Military: 10 Predictions for the Next Decade
The military landscape has always been a dynamic arena, shaped by technological advancements, geopolitical shifts, and evolving threats. As we stand in 2025, the world is on the cusp of transformative... 
Via MarketMinute
Topics Artificial Intelligence Climate Change Energy
Exposures Artificial Intelligence Climate Electricity Generation
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs. 
Via Investor's Business Daily
Topics Government
Exposures Political
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV. 
Via Benzinga
Jim Cramer Says Illumina Is 'Challenged,' Recommends Selling This Industrial Stock
Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and Arista Networks. 
Via Benzinga
Nvidia Stock Reached All-Time Highs After Jensen Huang's CES Keynote — Will Next Week's GTC Spark Another Surge?
Jensen Huang will give a keynote speech at Nvidia's GTC conference next week. A keynote from Huang at CES earlier this year took Nvidia stock to highs. 
Via Benzinga
Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China sales recovering faster than expected. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.